Published in Cancer Weekly, October 10th, 2000
The study, conducted by the Mayo Clinic Cancer Center in Rochester, Minnesota and published in the September 2000 edition of Mayo Clinic Proceedings, showed that one-fourth of patients with advanced multiple myeloma enrolled in the study responded to thalidomide therapy after failing conventional medical treatments.
"That's encouraging information because thalidomide is the first drug in over two decades that is...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.